Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-85
SponsorTel-Aviv Sourasky Medical Center

About this trial

This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.

Eligibility criteria

Qualifiers

Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);

Hoehn & Yahr stage II-III (ON-medication state);

Able to walk independently for ≥5 minutes;

Stable medication for ≥1 month;

Disqualifiers

Musculoskeletal, neurological, or visual/hearing impairments affecting gait;

Cognitive impairments or severe behavioral symptoms;

History of stroke, severe TBI, or brain tumor;

Cardiovascular contraindications;

Trial design

Treatments tested in this trial

  • Walking Tall App

Treatment groups

30 Participants
are divided into 1 treatment group